Status:
WITHDRAWN
Influence of Plasma Rich in Growth Factors (PRGF) on Healing of Medial Collateral Ligament (MCL) Tear
Lead Sponsor:
Meir Medical Center
Conditions:
MCL Tear
Eligibility:
All Genders
18-40 years
Phase:
PHASE2
PHASE3
Brief Summary
To evaluate the influence of Plasma Rich in Growth Factors (PRGF) on the healing process of medial collateral ligament (MCL) tear.
Detailed Description
Autologous platelet-rich matrices may aid in the healing of ligaments \& tendons by promoting and accelerating tissue healing because of the release of growth factors including transforming growth fac...
Eligibility Criteria
Inclusion
- age 18-40 years old
- diagnosed MCL tear grade 2/3
Exclusion
- pregnancy
- mental or physical disabilities
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2009
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00743886
Start Date
January 1 2008
End Date
March 1 2009
Last Update
July 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel